Nitto Avecia
Comprehensive oligo solutions, from concept to commercial.
601 employees · est. 1995 · Milford, United States
Santaris Pharma
Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states.
est. 2003
Nitto Avecia is the older company (1995 vs 2003).
Side-by-Side Comparison
| Metric | Nitto Avecia | Santaris Pharma |
|---|---|---|
| Founded | ||
| Founded | 1995 older | 2003 |
| Headquarters | ||
| Headquarters | Milford, United States | Not tracked yet |
| Employees | ||
| Employees | 601 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Manufacturing, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series Unknown |
| Total Funding | ||
| Total Funding | Not tracked yet | $72.40M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oligonucleotides, Therapeutics, Pharmaceutical, CMO, Drug Development, Clinical Trials, Biotechnology-based Medicines, Process Validation, Analytical Services, Stability Services, Drug Substance, Drug Product, Clinical Development | RNA-targeted Therapies, LNA-based Drug Development, Biopharmaceutical, Clinical-stage Company, Infectious Diseases, Cardiometabolic Disorders, Drug Discovery, Pharmaceutical Partnerships, MiRNA Therapeutics, Patent Estate, Danish Biotech, US Operations |
| Website | ||
| Website | avecia.com | santaris.com |
About Nitto Avecia
Nitto Avecia is a leading player in the oligonucleotide market, offering comprehensive solutions for the development and production of these therapeutics. With over 25 years of experience, the company has positioned itself as a preferred partner for pharmaceutical innovators aiming to revolutionize...
About Santaris Pharma
Santaris Pharma is a clinical-stage biopharmaceutical company founded in 2003, headquartered in Denmark, and operating in the United States. The company specializes in pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states. Santaris Pharma's proprietary LN...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Nitto Avecia and Santaris Pharma — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Nitto Avecia and Santaris Pharma — by email.
Frequently Asked Questions
Compare Nitto Avecia with someone else
Start typing a company name or domain.